Deutsche Bank analyst Emmanuel Papadakis reiterated a Hold rating on GlaxoSmithKline today and set a price target of p1,450.00. The company’s shares opened today at p1,392.00. D ...

London: GSK plc has concluded the acquisition of efimosfermin alfa from Boston Pharmaceuticals in a USD 2 billion ...

GSK completes $2 billion acquisition of efimosfermin from Boston Pharmaceuticals: London, UK Wednesday, July 9, 2025, 09:00 Hrs [IST] GSK plc announced the completion of its previ ...

GSK has concluded the acquisition of efimosfermin alfa, an investigational therapeutic for serious liver disease (SLD), from ...

Efimosfermin showed promise in reducing liver fat and maintaining safety across multiple doses in adults with phenotypic MASH ...

Altimmune, Inc.'s Pemvidutide shows promise in MASH treatment with liver improvements and safety, despite market overreaction. Click for my ALT stock update.

"Liver fibrosis is a progressive condition caused by chronic liver injury from diseases like NASH, hepatitis B/C, alcohol-related liver disease, and autoimmune hepatitis. If untreated, it can lead ...

"Superfoods" such as honey, oysters, watermelon, and ginger may boost testosterone, sperm quality, and erectile function, according to a biochemical review.

The FDA launched a new Priority Review program, as uncertainty persists for the existing programme for paediatric disorders.